Literature DB >> 20680007

Conditional ablation of glycogen synthase kinase 3β in postnatal mouse kidney.

Yan Ge1, Jin Si, Li Tian, Shougang Zhuang, Lance D Dworkin, Rujun Gong.   

Abstract

Glycogen synthase kinase (GSK)3 is a ubiquitously expressed serine/threonine kinase existing in two isoforms, namely GSK3α and GSK3β. Aside from the long-recognized role in insulin signal transduction and glycogen biosynthesis, GSK3β has been recently coined as a master control molecule in nuclear factor-κB activation and inflammatory kidney injury. Nevertheless, previous studies are less conclusive because they relied greatly on small molecule inhibitors, which lack selectivity and barely distinguish between the GSK3 isoforms. In addition, early embryonic lethality after global knockout of GSK3β precludes interrogation of the biological role of GSK3β in the adult kidney. To circumvent these issues, the Cre/loxP system was used to generate a conditional knockout mouse model in which the GSK3β gene was specifically deleted in kidney cortical tubules at postnatal mature stage. Kidney-specific ablation of GSK3β resulted in a phenotype no different from control littermates. Knockout mice (KO) were viable and exhibited normal development and normal kidney physiology in terms of kidney function, urine albumin excretion, and urine-concentrating ability. It is noteworthy that apart from normal glomerular and tubulointerstitial morphology, the kidneys from KO demonstrated more glycogen accumulation in the renal cortical tubules as assessed by both periodic acid-Schiff staining for light microscopy and direct biochemical assay, consistent with an elevated glycogen synthetic activity as evidenced by diminished inhibitory phosphorylation of glycogen synthase that occurred subsequent to GSK3β ablation. This finding was further validated by electron microscopic observations of increased deposition of glycogen particles in the renal tubules of KO, suggesting that GSK3α could not fully compensate for the loss of GSK3β in regulating glycogen metabolism in the kidney. Collectively, our study suggests that kidney-specific ablation of GSK3β barely affects kidney function and histology under normal circumstances. Extended examinations of these KO under diseased conditions are merited to understand the role of GSK3β in renal pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680007     DOI: 10.1038/labinvest.2010.142

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Authors:  Changbin Li; Yan Ge; Lance Dworkin; Ai Peng; Rujun Gong
Journal:  J Pathol       Date:  2016-03-16       Impact factor: 7.996

Review 2.  Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Authors:  Zhangsuo Liu; Rujun Gong
Journal:  Am J Kidney Dis       Date:  2015-08-10       Impact factor: 8.860

3.  Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.

Authors:  Zhen Wang; Hui Bao; Yan Ge; Shougang Zhuang; Ai Peng; Rujun Gong
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

4.  Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury.

Authors:  Meenalakshmi M Mariappan; Sanjay Prasad; Kristin D'Silva; Esteban Cedillo; Kavithalakshmi Sataranatarajan; Jeffrey L Barnes; Goutam Ghosh Choudhury; Balakuntalam S Kasinath
Journal:  J Biol Chem       Date:  2014-10-22       Impact factor: 5.157

5.  Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury.

Authors:  Juan Carlos Q Velez; Ehtesham Arif; Jessalyn Rodgers; Megan P Hicks; John M Arthur; Deepak Nihalani; Evelyn T Bruner; Milos N Budisavljevic; Carl Atkinson; Wayne R Fitzgibbon; Michael G Janech
Journal:  J Am Soc Nephrol       Date:  2017-02-15       Impact factor: 10.121

Review 6.  What we need to know about the effect of lithium on the kidney.

Authors:  Rujun Gong; Pei Wang; Lance Dworkin
Journal:  Am J Physiol Renal Physiol       Date:  2016-04-27

7.  Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.

Authors:  Sijie Zhou; Pei Wang; Yingjin Qiao; Yan Ge; Yingzi Wang; Songxia Quan; Ricky Yao; Shougang Zhuang; Li Juan Wang; Yong Du; Zhangsuo Liu; Rujun Gong
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

8.  Redox-sensitive glycogen synthase kinase 3β-directed control of mitochondrial permeability transition: rheostatic regulation of acute kidney injury.

Authors:  Zhen Wang; Yan Ge; Hui Bao; Lance Dworkin; Ai Peng; Rujun Gong
Journal:  Free Radic Biol Med       Date:  2013-08-22       Impact factor: 7.376

9.  Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury.

Authors:  Hao Bao; Yan Ge; Shougang Zhuang; Lance D Dworkin; Zhihong Liu; Rujun Gong
Journal:  Kidney Int       Date:  2012-01-18       Impact factor: 10.612

10.  Specific deletion of glycogen synthase kinase-3β in the renal proximal tubule protects against acute nephrotoxic injury in mice.

Authors:  Christiana Howard; Shixin Tao; Hai-Chun Yang; Agnes B Fogo; James R Woodgett; Raymond C Harris; Reena Rao
Journal:  Kidney Int       Date:  2012-07-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.